The physical properties of rectal contents have effects on anorectal continence: Insights from a study into the cause of fecal spotting on orlistat

Diseases of the Colon and Rectum

Volumn 47, Issue 12, 2004, Pages 2147-2156

  Fox, Mark ^a   Schwizer, Werner ^a   Menne, Dieter ^b   Stutz, Bernadette ^a   Fried, Michael ^a   Thumshirn, Miriam ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Menne Biomed   (Germany)

Author keywords

Anal manometry; Anorectal function; Fecal continence; Orlistat; Physical properties of rectal contents; Rectal barostat; Retention test; Stool consistency

Indexed keywords

ENEMA; FATTY ACID; OIL; TETRAHYDROLIPSTATIN;

ADULT; ANORECTAL PRESSURE; ARTICLE; BAROSTAT; CONTINENCE; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; MANOMETRY; MELENA; NORMAL HUMAN; PHYSIOLOGY; PRESSURE MEASUREMENT; QUANTITATIVE ANALYSIS; VISCOSITY;

ADMINISTRATION, ORAL; ADULT; ANAL CANAL; ANALYSIS OF VARIANCE; ANTI-OBESITY AGENTS; CAUSALITY; CROSS-OVER STUDIES; DEFECATION; ENEMA; FATTY ACIDS, NONESTERIFIED; FECAL INCONTINENCE; FECES; FEMALE; GASTROINTESTINAL CONTENTS; HUMANS; INTESTINAL ABSORPTION; LACTONES; LINEAR MODELS; MALE; MANOMETRY; METABOLIC CLEARANCE RATE; PLANT OILS; RECTUM; SENSATION; VISCOSITY;

EID: 13144260687     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-0739-0     Document Type: Article

References (20)

1. Hauptman JB, Jeunet FS, Hartmann D. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am J Clin Nutr 1992; 55:309S-13S.
2. Zhi J, Melia AT, Guerciolini R, et al. Retrospective population-based analysis of the close-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994;56:82-5.
3. Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998;352: 167-72.
4. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999;281:235-42.
5. Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000;8:49-61.
6. Zhi J, Melia AT, Eggers H, Joly R, Patel IH. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. J Clin Pharmacol 1995;35: 1103-8.
7. Ammon HV, Phillips SF. Inhibition of colonic water and electrolyte absorption by fatty acids in man. Gastroenterology 1973;65:744-9.
8. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology 1986;91:100-7.
9. Bannister JJ, Davison P, Timms JM, Gibbons C, Read NW. Effect of stool size and consistency on defecation. Gut 1987;28:1246-50.
10. Ambroze WL, Pemberton JH, Bell AM, Brown ML, Zinsmeister AR. The effect of stool consistency on rectal and neorectal emptying. Dis Colon Rectum 1991;34:1-7.
11. Fox M, Thumshirn M, Menne D, Stutz B, Fried M, Schwizer W. Evaluation of anorectal function in subjects receiving orlistat. Aliment Pharmacol Ther 2004; 19:311-21.
12. Hadvary P, Sidler W, Meister W, Vetter W, Wolfer H. The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. J Biol Chem 1991;266:2021-7.
13. Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci 1997;42:223-41.
14. Hammer H, Phillips A, Camilleri M, Hanson R. Rectal tone, distensibility, and perception: reproducibilty and response to different distensions. Am J Physiol Gastrointest Liver Physiol 1998;274:G584-9.
15. Fox M, Menne D, Fried M, Schwizer W, Thumshirn M. The measurement of rectal capacity by barostat techniques. Gut 2003;52:A91.
16. Fox M, Thumshirn M, Menne D, Fried M, Schwizer W. Anal sphincter pressure and rectal capacity affect anorectal sensation and continence in health. Gastroenterology 2004;126:M1578.
17. Read NW, Harford WV, Schmulen AC, Read MG, Santa Ana C, Fordtran JS. A clinical study of patients with fecal incontinence and diarrhea. Gastroenterology 1979;76:747-56.
18. Read NW, Bartolo DC, Read MG. Differences in anal function in patients with incontinence to solids and in patients with incontinence to liquids. Br J Surg 1984;71: 39-42.
19. Miller R, Bartolo DC, Roe A, Cervero F, Mortensen NJ. Anal sensation and the continence mechanism. Dis Colon Rectum 1988;31:433-8.
20. Bielefeldt K, Enck P, Zamboglou N, Moedder U, Erckenbrecht JF. Anorectal manometry and defecography in the diagnosis of fecal incontinence. J Clin Gastroenterol 1991;13:661-5.